Morgan Joseph

MORGAN JOSEPH ADDS TWO SENIOR BANKERS TO ITS HEALTHCARE INVESTMENT BANKING GROUP, EXPANDING GROUP TO TEN PROFESSIONALS

Jill S. Steier, a 20-Year Wall Street Veteran, is Named a Managing Director; Jennifer Meyers, With 11 Years Experience, Joins as a Director
6/14/10

NEW YORK, NY, June 14, 2010 – Morgan Joseph & Co. Inc., a full-service investment banking firm serving the middle market, today announced the appointment of two senior bankers to its Healthcare Investment Banking Group, expanding the group to ten professionals. Jill Steier, with over 20 years of banking experience, was named a Managing Director, and Jennifer Meyers, with 11 years of investment banking experience, joined as a Director. Both Ms. Steier and Ms. Meyers will be based in the firm’s New York City headquarters.

Within the group, Ms. Steier will continue her coverage of the life sciences, molecular diagnostics, regenerative medicine and healthcare IT sectors. Throughout her career, she has advised her healthcare clients on a range of corporate finance needs, including public equity offerings, private placements and strategic M&A advisory. Prior to joining Morgan Joseph, Ms. Steier has held senior positions with boutique investment banks Pennsylvania Merchant Group and, more recently, Emerging Growth Equities. She began her career at Prudential-Bache Capital Markets.

Ms. Meyers joins the Healthcare Group having spent her career as a specialist in mergers & acquisitions, focused primarily on the healthcare sector. Previously, Ms. Meyers was a Director in the Global Mergers & Acquisitions Group at Bank of America Merrill Lynch, where she executed numerous strategic advisory assignments involving healthcare services and medical technology companies. Prior to that, she was a member of the Global Mergers & Acquisitions Group at JPMorgan Chase.

“Healthcare remains a core industry focus for our firm,” said John Sorte, Chief Executive Officer at Morgan Joseph. “We’ve spent six years building a national effort and are well positioned now that healthcare reform legislation has passed and industry executives and investors are back in business. The Healthcare Group is now one of our largest efforts and is engaged in a wide range of active advisory and financing assignments. Having Jill and Jennifer join their team heightens our already existing broad capabilities, and is indicative of the opportunities we see in this vital sector. We are delighted to have both aboard.”